Found: 5
Select item for more details and to access through your institution.
Preclinical Pharmacology and Safety of a Novel Avidin Derivative for Tissue-Targeted Delivery of Radiolabelled Biotin.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2011, v. 109, n. 3, p. 145, doi. 10.1111/j.1742-7843.2011.00701.x
- By:
- Publication type:
- Article
Therapeutic efficacy of intra-tumor AvidinOX and low systemic dose biotinylated cetuximab, with and without cisplatin, in an orthotopic model of head and neck cancer.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 3529
- By:
- Publication type:
- Article
Chemical Linkage to Injected Tissues Is a Distinctive Property of Oxidized Avidin.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021075
- By:
- Publication type:
- Article
ErbB2 Targeted Epigenetic Modulation: Anti-tumor Efficacy of the ADC Trastuzumab-HDACi ST8176AA1.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01534
- By:
- Publication type:
- Article
OXavidin for Tissue Targeting Biotinylated Therapeutics.
- Published in:
- Journal of Biomedicine & Biotechnology, 2009, p. 1, doi. 10.1155/2009/921434
- By:
- Publication type:
- Article